Brought to you by:
Vascular Therapies completes enrollment in the ACCESS 2 study
Vascular Therapies has today announced completion of enrollment in the ACCESS 2 trial, a Phase III prospective randomized, multicenter clinical study of Sirogen for the surgical creation of arteriovenous (AV) fistula in patients requiring hemodialysis vascular access. Vascular Therapies developed…
SVS History Work Group’s landmark project culminates in new book
The 2024 Vascular Annual Meeting (VAM) saw the culmination of a decade-long project by the Society for Vascular Surgery’s (SVS) History Project Work Group. The release of the book, Legends Leaders Pioneers: Surgeons Who Built Vascular Surgery, marks a significant…
Silk Road celebrates milestone of 100,000 TCAR procedures
Silk Road Medical has announced the milestone of more than 100,000 transcarotid artery revascularisation (TCAR) procedures having been performed to date. “A growing number of patients come to us looking for a solution that is minimally invasive and requires less…
CIRSE begins CALCIO trial enrolment for treatment of CLTI with Shockwave IVL system
The Cardiovascular and Interventional Society of Europe (CIRSE) have announced that patient enrolment for the CALCIO trial has begun. CALCIO started patient enrolment on 15 July, 2024, with the goal of recruiting 400 chronic limb-threatening ischaemia (CLTI) patients over the…
Thrombolex and Aidoc announce strategic partnership to advance breakthrough PE treatment
Thrombolex and Aidoc have announced a strategic partnership aimed at revolutionising the treatment of acute pulmonary embolism (PE), a press release reports. This strategic collaboration, the release details, will leverage Aidoc’s artificial intelligence (AI) technology to accelerate patient identification and…
CEA and TCAR should be ‘first-line’ interventions for weekend carotid revascularization, researchers advise
Patients who undergo carotid revascularization at the weekend have increased odds of complications and mortality, with transfemoral carotid artery stenting (TFCAS) posing the highest risk and transcarotid artery revascularization (TCAR) the lowest, compared to carotid endarterectomy (CEA). This is one…
Machine learning-based model could aid in determining EVAR suitability
Researchers at the University Medical Center Groningen (Groningen, The Netherlands) and the University of Twente (Enschede, The Netherlands) have developed a prediction model that they claim could assist in the preoperative identification of patients who are unlikely to achieve sufficient…
One-year STRIDE study data show ‘meaningful’ limb salvage, mortality and QoL outcomes
One-year outcomes from the STRIDE study of the Indigo aspiration thrombectomy system (Penumbra) for lower-extremity acute limb ischemia (ALI) showed target limb salvage and mortality rates of 88.5% and 12%, respectively. The data were revealed by Thomas Maldonado, MD, professor…
PRESERVE II trial shows robust five-year outcomes
Five-year outcomes the PRESERVE II pivotal trial of Cook Medical’s Zenith branch iliac graft (ZBIS) demonstrate “sustained safety and effectiveness” when combined with the iCast (Getinge) covered stent for the treatment of aortoiliac aneurysms and preservation of hypogastric artery perfusion,…
‘Well, here we are—but right now I wish I wasn’t’: Early-career errors
On Friday, June 21, the Society for Vascular Surgery (SVS) Young Surgeons Section (YSS) held their session at the 2024 Vascular Annual Meeting (VAM). The session began with Chelsea Dorsey, MD, highlighting the YSS’ achievements from the last year including…